MC
EXAS

Mayo Clinic’s Exact Sciences EXAS Stock Holding History

Mayo Clinic’s Portfolio EXAS Stock Details EXAS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q3 		– Sell
-3,167
Closed -$297K – 11
2023
Q2 		$297K Sell
3,167
-1,984
-39% -$155K 0.31% 6
2023
Q1 		$349K Buy
5,151
+1,496
+41% +$96.2K 0.29% 4
2022
Q4 		$181K Buy
+3,655
New +$149K 0.1% 10
2021
Q1 		– Sell
-1,304
Closed -$173K – 9
2020
Q4 		$173K Sell
1,304
-1,985
-60% -$240K 0.21% 9
2020
Q3 		$3.35M Buy
+3,289
New +$284K 4.52% 6
2020
Q2 		– Sell
-3,795
Closed -$220K – 10
2020
Q1 		$220K Hold
3,795
– – 0.56% 6
2019
Q4 		$351K Buy
+3,795
New +$334K 0.4% 6

Other funds holding EXAS

JP Morgan Chase
JP Morgan Chase New York $1.47T AUM 27.86% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
AIM
ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $61.3B AUM 26.25% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $431B AUM 30.22% 1-Year Est. Return